Marek’s Disease Virus-Induced T-Cell Lymphomas

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4614-0016-5_13
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Protective immunity of a meq-deleted Marek's disease virus against very virulent virus challenge in chickens].

  2010cited by this paper
• Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.

  2010cited by this paper
• Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays.

  2010cited by this paper
• Both homo and heterodimers of Marek's disease virus encoded Meq protein contribute to transformation of lymphocytes in chickens.

  2010cited by this paper
• Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek’s disease virus (MDV)

  2010cited by this paper
• Identification of an Intercistronic Internal Ribosome Entry Site in a Marek's Disease Virus Immediate-Early Gene

  2009cited by this paper
• MicroRNAs in Cancer.

  2009cited by this paper
• The conserved NAD(H)-dependent corepressor CTBP-1 regulates Caenorhabditis elegans life span

  2009cited by this paper
• Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines.

  2009cited by this paper
• MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells

  2009cited by this paper
• Homodimerization of the Meq Viral Oncoprotein Is Necessary for Induction of T-Cell Lymphoma by Marek's Disease Virus

  2009cited by this paper
• Interaction of Marek's disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells.

  2009cited by this paper
• Suppressive role of C-terminal binding protein 1 in IL-4 synthesis in human T cells.

  2009cited by this paper
• The 5′ Leader of the mRNA Encoding the Marek's Disease Virus Serotype 1 pp14 Protein Contains an Intronic Internal Ribosome Entry Site with Allosteric Properties

  2009cited by this paper
• MicroRNAs of Gallid and Meleagrid herpesviruses show generally conserved genomic locations and are virus-specific.

  2009cited by this paper
• Breaking the chains: structure and function of the deubiquitinases

  2009cited by this paper
• The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.

  2009cited by this paper
• MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1.

  2009cited by this paper
• Epstein-Barr Virus Nuclear Protein 3C Domains Necessary for Lymphoblastoid Cell Growth: Interaction with RBP-Jκ Regulates TCL1

  2009cited by this paper
• In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.

  2009cited by this paper
• MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

  2008cited by this paper
• Sequence Conservation and Differential Expression of Marek's Disease Virus MicroRNAs

  2008cited by this paper
• Identification of a Second CtBP Binding Site in Adenovirus Type 5 E1A Conserved Region 3

  2008cited by this paper
• Marek's Disease Virus Induces Th-2 Activity During Cytolytic Infection

  2008cited by this paper
• Selected aspects of cancer progression : metastasis, apoptosis and immune response

  2008cited by this paper
• BACH1 Is a Specific Repressor of HMOX1 That Is Inactivated by Arsenite*

  2008cited by this paper
• Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR.

  2008cited by this paper
• Immunological aspects of Marek’s disease virus (MDV)-induced lymphoma progression

  2008cited by this paper
• The neoplastically transformed (CD30hi) Marek’s disease lymphoma cell phenotype most closely resembles T-regulatory cells

  2008cited by this paper
• A Functional MicroRNA-155 Ortholog Encoded by the Oncogenic Marek's Disease Virus

  2008cited by this paper
• Different signaling pathways expressed by chicken naive CD4(+) T cells, CD4(+) lymphocytes activated with staphylococcal enterotoxin B, and those malignantly transformed by Marek's disease virus.

  2008cited by this paper
• Homodimerization of Marek's Disease Virus-Encoded Meq Protein Is Not Sufficient for Transformation of Lymphocytes in Chickens

  2008cited by this paper
• MicroRNA Profile of Marek's Disease Virus-Transformed T-Cell Line MSB-1: Predominance of Virus-Encoded MicroRNAs

  2008cited by this paper
• A viral microRNA functions as an orthologue of cellular miR-155

  2007cited by this paper
• Requirement of bic/microRNA-155 for Normal Immune Function

  2007cited by this paper
• Role of the PLDLS-Binding Cleft Region of CtBP1 in Recruitment of Core and Auxiliary Components of the Corepressor Complex

  2007cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155

  2007cited by this paper
• Modeling the proteome of a Marek's disease transformed cell line: a natural animal model for CD30 overexpressing lymphomas

  2007cited by this paper
• Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus.

  2007cited by this paper
• A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation

  2007cited by this paper
• Transcriptional regulation by C-terminal binding proteins.

  2007cited by this paper
• Marek's Disease Virus Type 2 (MDV-2)-Encoded MicroRNAs Show No Sequence Conservation with Those Encoded by MDV-1

  2007cited by this paper
• Nuclear Localization and Dynamic Properties of the Marek's Disease Virus Oncogene Products Meq and Meq/vIL8

  2006cited by this paper
• Marek's Disease Virus Encodes MicroRNAs That Map to meq and the Latency-Associated Transcript

  2006cited by this paper
• A mass spectrometry-based proteomic approach to study Marek's Disease Virus gene expression.

  2006cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis

  2006cited by this paper
• Somatic Excision Demonstrates that c-Jun Induces Cellular Migration and Invasion through Induction of Stem Cell Factor

  2006cited by this paper
• Multiple alternative splicing to exons II and III of viral interleukin-8 (vIL-8) in the Marek’s disease virus genome: the importance of vIL-8 exon I

  2006cited by this paper
• Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus.

  2006cited by this paper
• Marek's disease virus: from miasma to model

  2006cited by this paper
• Marek's Disease Virus–Induced Transient Paralysis Is Associated with Cytokine Gene Expression in the Nervous System

  2006cited by this paper
• Pro-inflammatory Responses in Chicken Spleen and Brain Tissues after Infection with Very Virulent Plus Marek's Disease Virus

  2005cited by this paper
• Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses.

  2005cited by this paper
• Comparative Functional Study of the Viral Telomerase RNA Based on Natural Mutations*

  2005cited by this paper
• Apoptosis and CD8-down-regulation in the thymus of chickens infected with Marek's disease virus

  2005cited by this paper
• Attenuation of Marek's Disease Virus by Deletion of Open Reading Frame RLORF4 but Not RLORF5a

  2005cited by this paper
• Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

  2005cited by this paper
• A Marek's Disease Virus vIL-8 Deletion Mutant Has Attenuated Virulence and Confers Protection Against Challenge with a Very Virulent Plus Strain

  2005cited by this paper
• Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30).

  2004cited by this paper
• Immunity to Marek's disease

  2004cited by this paper
• Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.

  2004cited by this paper
• Marek's disease virus-induced transient paralysis in chickens: alterations in brain density

  2004cited by this paper
• Pathogenesis of a Marek's Disease Virus Mutant Lacking vIL-8 in Resistant and Susceptible Chickens

  2004cited by this paper
• Marek's Disease Virus-Encoded vIL-8 Gene Is Involved in Early Cytolytic Infection but Dispensable for Establishment of Latency

  2004cited by this paper
• Marek's disease virus: Biology and life cycle

  2004cited by this paper
• Marek's Disease Herpesvirus Transforming Protein MEQ: a c-Jun Analogue with an Alternative Life Style

  2004cited by this paper
• Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.

  2004cited by this paper
• Characterization of the Chromosomal Binding Sites andDimerization Partners of the Viral Oncoprotein Meq in Marek'sDisease Virus-Transformed TCells

  2003cited by this paper
• Marek's Disease Virus Latent Protein MEQ: Delineation of an Epitope in the BR1 Domain Involved in Nuclear Localization

  2003cited by this paper
• The RNA Subunit of Telomerase Is Encoded by Marek's Disease Virus

  2003cited by this paper
• Impact of Deletions within the Bam HI-L Fragment of Attenuated Marek's Disease Virus on vIL-8 Expression and the Newly Identified Transcript of Open Reading Frame LORF4

  2003cited by this paper
• Differential Cytokine Responses following Marek's Disease Virus Infection of Chickens Differing in Resistance to Marek's Disease

  2003cited by this paper
• Characterization of a spontaneously transformed chicken mononuclear cell line.

  2003cited by this paper
• Resistance and susceptibility to Marek's disease: nitric oxide synthase/arginase activity balance.

  2002cited by this paper
• Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek's disease.

  2002cited by this paper
• Antiviral and antitumoral effects of recombinant chicken myelomonocytic growth factor in virally induced lymphoma.

  2002cited by this paper
• Neuropathotyping: A New System to Classify Marek's Disease Virus

  2002cited by this paper
• Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: Use of a pp38 mutant to validate the technology for the study of gene function

  2002cited by this paper
• Protective Effect of Avian Myelomonocytic Growth Factor in Infection with Marek’s Disease Virus

  2002cited by this paper
• Two Nonconsensus Sites in the Epstein-Barr Virus Oncoprotein EBNA3A Cooperate to Bind the Co-repressor Carboxyl-terminal-binding Protein (CtBP)*

  2002cited by this paper
• Avian bic, a Gene Isolated from a Common Retroviral Site in Avian Leukosis Virus-Induced Lymphomas That Encodes a Noncoding RNA, Cooperates with c-myc in Lymphomagenesis and Erythroleukemogenesis

  2002cited by this paper
• BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

  2001cited by this paper
• Meq: an MDV-specific bZIP transactivator with transforming properties.

  2001cited by this paper
• Marek's Disease Virus (MDV) Encodes an Interleukin-8 Homolog (vIL-8): Characterization of the vIL-8 Protein and a vIL-8 Deletion Mutant MDV

  2001cited by this paper
• Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken

  2001cited by this paper
• Marek’s Disease

  2001cited by this paper
• Four distinct neurologic syndromes in Marek's disease: effect of viral strain and pathotype.

  1999cited by this paper
• Functional Interactions between Herpesvirus Oncoprotein MEQ and Cell Cycle Regulator CDK2

  1999cited by this paper
• MEQ and V-IL8: cellular genes in disguise?

  1999cited by this paper
• Transforming Potential of the Herpesvirus Oncoprotein MEQ: Morphological Transformation, Serum-Independent Growth, and Inhibition of Apoptosis

  1998cited by this paper
• Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B.

  1998cited by this paper
• Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication.

  1997cited by this paper
• Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ

  1997cited by this paper
• Characterization of Marek’s disease herpesvirus‐specific cytotoxic T lymphocytes in chickens inoculated with a non‐oncogenic vaccine strain of MDV

  1997cited by this paper
• Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count

  1997cited by this paper
• Increased virulence of Marek's disease virus field isolates.

  1997cited by this paper
• Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone

  1996cited by this paper
• Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells

  1996cited by this paper

• Can Oncogenic Animal Viruses Pose a Threat to Humans?

  2025cites this paper
• A Special Issue on Marek’s Disease Virus—The Editors’ View

  2023cites this paper
• A Cell Culture System to Investigate Marek’s Disease Virus Integration into Host Chromosomes

  2021cites this paper
• Abrogation of Marek’s disease virus replication using CRISPR/Cas9

  2020cites this paper
• Role of DNA Methylation and CpG Sites in the Viral Telomerase RNA Promoter during Gallid Herpesvirus 2 Pathogenesis

  2020cites this paper
• The Role of Marek’s Disease Virus UL12 and UL29 in DNA Recombination and the Virus Lifecycle

  2019cites this paper
• Marek's Disease Virus-Encoded MicroRNA 155 Ortholog Critical for the Induction of Lymphomas Is Not Essential for the Proliferation of Transformed Cell Lines

  2019cites this paper
• Neoplastic Diseases

  2019cites this paper
• Unraveling the role of B cells in the pathogenesis of an oncogenic avian herpesvirus

  2018cites this paper
• The role of polycomb repressive complex proteins in Marek's Disease Virus (MDV) latency and lymphomagenesis

  2018cites this paper
• Epstein-Barr virus-encoded RNAs (EBERs) complement the loss of Herpesvirus telomerase RNA (vTR) in virus-induced tumor formation

  2018cites this paper
• Viral Factors Involved in Marek’s Disease Virus (MDV) Pathogenesis

  2018cites this paper
• Application of CRISPR/Cas9 Gene Editing System on MDV-1 Genome for the Study of Gene Function

  2018cites this paper
• Tumor promoting functions of cellular telomerase RNA and viral RNAs in herpesvirus-induced cancer formation

  2017influential citation
• Telomeres and Telomerase: Role in Marek’s Disease Virus Pathogenesis, Integration and Tumorigenesis

  2017cites this paper
• Innate patterning of the immune response to Marek's disease virus (MDV) during pathogenesis and vaccination

  2015influential citation
• The effect of mutations in the Meq oncoprotein of Marek's disease virus (MDV) on lymphomas composition

  2014cites this paper
• Latency and Tumorigenesis in Marek's Disease

  2013cites this paper
• Microorganisms

  1964cites this paper